Abstract
Aims
To assess whether a single parental dose of 25-hydroxy vitamin D [25(OH)Vit D] could improve glucose control and inflammation in type 2 diabetic patients (T2D) with ischemic heart disease (IHD).
Methods
A randomized, placebo-controlled, double-blind trial was performed on 95 patients (47—placebo and 48—vitamin D groups). Participants were randomized using a randomization table to a single dose of either vitamin D (300,000 IU, IM) or a matching placebo. Fasting blood sugar (FBS), glycosylated hemoglobin (HbA1c), 25(OH)Vit D and high-sensitivity C-reactive protein (hs-CRP) were measured at baseline and at 8 weeks.
Results
No significant differences in baseline values were noted between groups, except in HbA1c, which was lower in the placebo group. In the supplemented group, the level of serum 25(OH)Vit D increased (29.6 ± 20.8 vs. 44.5 ± 19.2 ng/mL) and those of FBS and HbA1c decreased significantly [186.5 ± 64.1 vs. 165.1 ± 58.5 mg/dL and 8.2 ± 2.0 % (66.3 ± 21.8 mmol/mol) vs. 7.7 ± 1.8 % (61.7 ± 20.0 mmol/mol), respectively] (all p < 0.05), and no changes, however, were observed in the placebo group. We also compared change of marginal means of outcome variables (HbA1c, FBS, 25(OH)Vit D and hs-CRP) from baseline between the vitamin D versus placebo group, using ANCOVA, adjusted for the baseline of each variable itself, season at study entry, age and body mass index. During trial, only HbA1c level decreased significantly [0.48 % (standard error: 0.17), p = 0.04]. No any adverse effect was seen.
Conclusions
A single parenteral dose of vitamin D in T2D patients with IHD improved glycemic control, but not inflammatory status.
Clinical trial registry
Australian New Zealand Clinical Trial Registry.
Clinical trial number
ACTRN12614000529640.
Similar content being viewed by others
References
Holick MF (2009) Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol 19(2):73–78. doi:10.1016/j.annepidem.2007.12.001
Muscogiuri G, Sorice G, Ajjan R et al (2012) Can vitamin D deficiency cause diabetes and cardiovascular diseases? present evidence and future perspectives. Nutr Metab Cardiovasc Dis 22(2):81–87. doi:10.1016/j.numecd.2011.11.001
Nikooyeh B, Neyestani TR, Alavi-Majd H et al (2014) Vitamin D deficiency is associated with the metabolic syndrome in subjects with type 2 diabetes. Nutr Food Sci Res 1(1):3–10
Hadaegh F, Bozorgmanesh MR, Ghasemi A, Harati H, Saadat N, Azizi F (2008) High prevalence of undiagnosed diabetes and abnormal glucose tolerance in the Iranian urban population: tehran lipid and glucose study. BMC Public Health 8:176. doi:10.1186/1471-2458-8-176
Chiu KCCA, Go VL, Saad MF (2004) Hypovitaminosis D is associated with insulin resistance and beta cell function. Am J Clin Nutr 79:820–825
Boucher BMN, Noonan K, Hales C, Evans S (1995) Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians. Diabetologia 38(10):1239–1245. doi:10.1007/BF00422375
Mitri J, Muraru M, Pittas A (2011) Vitamin D and type 2 diabetes: a systematic review. Eur J Clin Nutr 65(9):1005–1015. doi:10.3945/ajcn.111.011684
Holick MF (2007) Vitamin D deficiency. N Engl J Med 357(3):266–281. doi:10.1056/NEJMra070553
Tohidi M, Bozorgmanesh M, Mohebi R et al (2013) Non-linear association between 25-hydroxyvitamin D and the incidence of type 2 diabetes: a community-based nested case–control study. Diabet Med 30(8):934–938. doi:10.1111/dme.12180
Scragg R, Sowers M, Bell C (2004) Serum 25-hydroxyvitamin D3, diabetes and ethnicity in the third national health and nutrition examination survey. Diabetes Care 27:2813–2818. doi:10.2337/diacare.27.12.2813
Stadlmayr A, Aigner E, Huber-Schonauer U et al (2015) Relations of vitamin D status, gender and type 2 diabetes in middle-aged Caucasians. Acta Diabetol 52(1):39–46. doi:10.1007/s00592-014-0596-9
Palomer X, González-Clemente J, Blanco-Vaca F, Mauricio D (2008) Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes Metab 10(3):185–197. doi:10.1111/j.1463-1326.2007.00710.x
Lacroix M, Battista MC, Doyon M et al (2014) Lower vitamin D levels at first trimester are associated with higher risk of developing gestational diabetes mellitus. Acta Diabetol 51(4):609–616. doi:10.1007/s00592-014-0564-4
Pittas AG, Lau J, Hu FB, Dawson-Hughes B (2007) The role of Vitamin D and calcium in type 2 diabetes. A systemic review and metaanalysis. J Clin Endocrinol Metab 92:2017–2019. doi:10.1210/jc.2007-0298
Meerza D, Naseem I, Ahmed J (2010) Can Vitamin D be a potential treatment for Type 2 diabetes mellitus. Diabetes Metabol Syndr: Clin Res Rev 4(4):245–248. doi:10.1016/j.dsx.2010.09.001
Hewison M (2012) An update on vitamin D and human immunity. Clin Endocrinol (Oxf) 76:315–325. doi:10.1111/j.1365-2265.2011.04261.x
Chagas CEBM, Martini LA, Rogero MM (2012) Focus on vitamin D, inflammation and type 2 diabetes. Nutrients 4:52–67. doi:10.3390/nu4010052
Krul-Poel YH, Westra S, ten Boekel E et al (2015) Effect of vitamin D supplementation on glycemic control in patients with type 2 diabetes (SUNNY Trial): a randomized placebo-controlled trial. Diabetes Care. doi:10.2337/dc15-0323
Asemi Z, Samimi M, Tabassi Z, Shakeri H, Esmaillzadeh A (2013) Vitamin D supplementation affects serum high-sensitivity C-reactive protein, insulin resistance, and biomarkers of oxidative stress in pregnant women. J Nutr 143(9):1432–1438. doi:10.3945/jn.113.177550
Shab-Bidar S, Neyestani TR, Djazayery A et al (2011) Regular consumption of vitamin D-fortified yogurt drink (Doogh) improved endothelial biomarkers in subjects with type 2 diabetes: a randomized double-blind clinical trial. BMC Med 9(1):125. doi:10.1186/1741-7015-9-125
Bland JM, Altman DG (2015) Best (but oft forgotten) practices: testing for treatment effects in randomized trials by separate analyses of changes from baseline in each group is a misleading approach. Am J Clin Nutr 102(5):991–994. doi:10.3945/ajcn.115.119768
Neyestani TR, Hajifaraji M, Omidvar N et al (2012) High prevalence of vitamin D deficiency in school-age children in Tehran, 2008: a red alert. Public Health Nutr 15(02):324–330. doi:10.1017/S1368980011000188
Song Y, Wang L, Pittas AG et al (2013) Blood 25-hydroxy vitamin D levels and incident type 2 diabetes a meta-analysis of prospective studies. Diabetes Care 36(5):1422–1428. doi:10.2337/dc12-0962
Seida JC, Mitri J, Colmers IN et al (2014) Effect of vitamin D3 supplementation on improving glucose homeostasis and preventing diabetes: a systematic review and meta-analysis. J Clin Endocrinol Metab 99(10):3551–3560. doi:10.1210/jc.2014-2136
Parker J, Hashmi O, Dutton D et al (2010) Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis. Maturitas 65(3):225–236. doi:10.1016/j.maturitas.2009.12.013
Eftekhari MH, Akbarzadeh M, Dabbaghmanesh MH, Hasanzadeh J (2011) Impact of treatment with oral calcitriol on glucose indices in type 2 diabetes mellitus patients. Asia Pac J Clin Nutr 20(4):521
Kampmann U, Mosekilde L, Juhl C et al (2014) Effects of 12 weeks high dose vitamin D3 treatment on insulin sensitivity, beta cell function, and metabolic markers in patients with type 2 diabetes and vitamin D insufficiency: a double-blind, randomized, placebo-controlled trial. Metabolism 63(9):1115–1124. doi:10.1016/j.metabol.2014.06.008
Jorde R, Figenschau Y (2009) Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels. Eur J Nutr 48(6):349–354. doi:10.1007/s00394-009-0020-3
Witham M, Dove F, Dryburgh M, Sugden J, Morris A, Struthers A (2010) The effect of different doses of vitamin D3 on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia 53(10):2112–2119. doi:10.1007/s00125-010-1838-1
Al-Sofiani ME, Jammah A, Racz M et al (2015) Effect of vitamin D supplementation on glucose control and inflammatory response in type II diabetes: a double blind, randomized clinical trial. Int J Endocrinol Metab. doi:10.5812/ijem.22604
Mitri J, Dawson-Hughes B, Hu FB, Pittas AG (2011) Effects of vitamin D and calcium supplementation on pancreatic β cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and vitamin D for diabetes mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr 94(2):486–494. doi:10.3945/ajcn.111.011684
Sabherwal S, Bravis V, Devendra D (2010) Effect of oral vitamin D and calcium replacement on glycaemic control in South Asian patients with type 2 diabetes. Int J Clin Pract 64(8):1084–1089. doi:10.1111/j.1742-1241.2010.02372.x
Tabesh M, Azadbakht L, Faghihimani E, Tabesh M, Esmaillzadeh A (2014) Effects of calcium–vitamin D co-supplementation on metabolic profiles in vitamin D insufficient people with type 2 diabetes: a randomised controlled clinical trial. Diabetologia 57(10):2038–2047. doi:10.1007/s00125-014-3313-x
Nikooyeh B, Neyestani TR, Farvid M et al (2011) Daily consumption of vitamin D–or vitamin D+ calcium–fortified yogurt drink improved glycemic control in patients with type 2 diabetes: a randomized clinical trial. Am J Clin Nutr 93(4):764–771. doi:10.3945/ajcn.110.007336
Talaei A, Mohamadi M, Adgi Z (2013) The effect of vitamin D on insulin resistance in patients with type 2 diabetes. Diabetol Metab Syndr 5(1):8. doi:10.1186/1758-5996-5-8
Wood AD, Secombes KR, Thies F et al (2015) Vitamin D3 supplementation has no effect on conventional cardiovascular risk factors: a parallel-group, double-blind, placebo-controlled RCT. J Clin Endocrinol Metab 97(10):3557–3568. doi:10.1210/jc.2012-2126
Shah S, Wilson DM, Bachrach LK (2015) Large doses of vitamin D fail to increase 25-hydroxyvitamin D levels or to alter cardiovascular risk factors in obese adolescents: a pilot study. J Adolesc Health 57(1):19–23. doi:10.1016/j.jadohealth.2015.02.006
Chen N, Wan Z, Han S-F, Li B-Y, Zhang Z-L, Qin L-Q (2014) Effect of vitamin D supplementation on the level of circulating high-sensitivity C-reactive protein: a meta-analysis of randomized controlled trials. Nutrients 6(6):2206–2216. doi:10.3390/nu6062206
American Diabetes Association (2015) Standards of medical care in diabetes. Diabetes Care 38 (Suppl 1): S1–S2:51–594. doi:10.2337/dc15-S001
Acknowledgments
This study was funded by the Research Institute for Endocrine Sciences of Shahid Beheshti University of Medical Sciences (Grant No. 551). The authors wish to acknowledge Ms Niloufar Shiva for critical editing of English grammar and syntax of the manuscript. This manuscript is the result of a residency thesis in the clinical pharmacology of Dr Elnaz Shaseb in Shahid Beheshti University of Medical Sciences.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Ethical standard
Ethics committee of Shahid Beheshti University of Medical Science (8ECRIES- 2013) approved this study.
Human and animal rights
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008 (5).
Informed consent
Informed consent was obtained from all patients for being included in the study.
Additional information
Managed by Antonio Secchi.
Rights and permissions
About this article
Cite this article
Shaseb, E., Tohidi, M., Abbasinazari, M. et al. The effect of a single dose of vitamin D on glycemic status and C-reactive protein levels in type 2 diabetic patients with ischemic heart disease: a randomized clinical trial. Acta Diabetol 53, 575–582 (2016). https://doi.org/10.1007/s00592-016-0843-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00592-016-0843-3